Engflag

Cort-Dome

Quick links to important sections

Cort-Dome

There is no image.

Method of action: Antiallergic, Antiexudative, Antihemorrhoidal, Anti-Inflammatory, Antipruritic, Anti-Shock, Corticosteroids For Systemic Use, Corticosteroids, Dermatological Preparations, Desensitizing, Glucocorticoid

Treatment option: Addison's Disease, Allergic Conjunctivitis, Anaphylaxis, Anemia, Ankylosing Spondylitis, Arthritis,Osteoarthritis, Asthma, Atopic Dermatitis, Berylliosis, Crohn'S Disease

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cort-Dome

Property Description
Active Ingredient Hydrocortisone (Cortisol)
Form Cream, Ointment, Lotion, Solution, Suppository
Pharmacological Class Corticosteroid (Glucocorticoid)
Common Use Reduction of localized inflammation and associated symptoms
Origin Synthetic analogue of a natural hormone

What is Cort-Dome and What Class of Medicine Does it Belong To?

Cort-Dome is a distinct trade name for a medicinal preparation whose active pharmaceutical ingredient is hydrocortisone, which is the synthetic equivalent of the body's natural stress hormone, cortisol. This drug is fundamentally classified within the overarching category of corticosteroids and specifically as a glucocorticoid. Hydrocortisone functions as a synthetic analogue, replacing or supplementing the body's intrinsic regulating mechanism to control various biological processes. Hydrocortisone is classified as a low-potency agent among topical corticosteroid classes.

Hydrocortisone Composition and Available Forms

The core of Cort-Dome is the single active ingredient, hydrocortisone, manufactured into a variety of finished dosage forms. The medication is commonly supplied for topical administration as a cream, ointment, lotion, or solution, and for rectal administration as a suppository. This comprehensive range of preparations is intended to optimize delivery based on the treatment area. The specific base of the product, such as a water-repellent lipid base found in ointments or an oil-in-water emulsion base characteristic of creams, is crucial as it dictates the drug's penetration profile and localized delivery.

General Purpose: How Cort-Dome Helps

The general therapeutic purpose of Cort-Dome is to provide relief by addressing the underlying cause of localized inflammation and excessive immune reactions in affected tissues. Hydrocortisone accomplishes this by acting at a cellular level to inhibit the production and release of numerous biological signals that initiate and maintain the body’s inflammatory cascade. Glucocorticoids play an essential role in controlling inflammation. This anti-inflammatory and immunosuppressive action is clinically recognized for its effectiveness in alleviating characteristic symptoms such as redness, swelling, heat, and itching in scenarios like acute skin irritation.

What side effects are possible with Cort-Dome?

Cort-Dome, a product containing hydrocortisone, carries a safety profile consistent with topical corticosteroids. The risk and severity of side effects are generally related to the potency of the steroid, the duration of use, the surface area treated, and whether the treated area is covered or occluded.

Common Adverse Reactions (Local)

The most commonly reported adverse reactions are local and occur at the application site. These include burning, itching, irritation, dryness, or a scaly rash. These effects are typically mild and reversible.

Serious and Clinically Significant Risks

Prolonged or extensive use, particularly with high doses or under occlusion, can lead to systemic effects due to the absorption of the corticosteroid into the bloodstream. These serious risks involve several system-organ classes:

  • Endocrine System: Suppression of the hypothalamic-pituitary-adrenal (HPA) axis can occur, leading to Cushing's syndrome or adrenal insufficiency, especially in children and patients using the product for extended periods.
  • Dermatologic System: Localized skin reactions can become severe, including thinning of the skin (atrophy), easy bruising (ecchymosis), stretch marks (striae), and changes in skin pigmentation (hypo- or hyperpigmentation). Long-term use may also lead to the development of acne-like eruptions or perioral dermatitis.
  • Ophthalmic System: Use near the eyes carries a risk of cataracts and glaucoma, which can damage the optic nerves and impair vision.
  • Infections: Corticosteroid use may mask the signs of an existing infection or enhance the establishment of new infections.

Population-Specific Safety Notes

Pediatric Patients are generally more susceptible to systemic toxicity, including HPA axis suppression and Cushing's syndrome, due to a higher ratio of skin surface area to body weight. Growth and development should be carefully observed in children on prolonged therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

Cort-Dome (topical hydrocortisone) overdose symptoms typically result not from a single, acute exposure but from prolonged use or systemic absorption of excessive amounts of the medication.

Documented Overdose Presentations and Risks

Official regulatory information describes the main concern as suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis and the potential manifestation of Cushing’s Syndrome.

Overdose Domain Specific Manifestations
Systemic Toxicity HPA axis suppression, Cushing’s Syndrome, hyperglycemia
Risk Factors Use on large surface areas, prolonged duration of use, use under occlusive dressings

When to Seek Immediate Medical Attention

Immediate medical attention is required if signs of systemic toxicity are observed during or following the use of Cort-Dome. This includes symptoms consistent with HPA axis suppression or Cushing's Syndrome.

Overdose Management

In the event of overexposure, the documented management strategy involves the gradual withdrawal of the drug or substitution with a less potent corticosteroid, as immediate cessation may be harmful due to HPA axis suppression. Symptomatic treatment is otherwise required to manage any adverse effects. Pediatric patients may be at increased risk due to a higher skin surface area to body weight ratio, making them more susceptible to systemic effects from excessive absorption.

Therapeutic Uses of Cort-Dome

What Cort-Dome treats: Main Uses and Benefits

Cort-Dome is used in therapeutic areas involving inflammatory or irritative states and where symptoms create noticeable physiological strain. The medication is considered relevant in contexts where short-term symptomatic assistance is needed. It offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.

This medication is commonly used across conditions presenting with acute episodes, targeting the specific inflammatory and pruritic manifestations of mild-to-moderate dermatoses, including eczema, contact dermatitis, and minor irritations. The preparation is also applied across domains where additional symptomatic support is needed for localized anorectal inflammation, such as inflamed hemorrhoids (piles) and specific inflammatory conditions like localized ulcerative proctitis.

It helps address symptom clusters that may become intense or disruptive, providing support that helps ease the overall symptom burden of redness, swelling, and persistent itching.

“It assists with maintaining functional stability by easing the localized soreness and discomfort often associated with these inflammatory periods.”

Quick Fact: Relief for Inflammatory Symptoms Cort-Dome is often used during phases when symptoms become more noticeable, and is relevant when supportive symptom management is appropriate, contributing to improved comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cort-Dome?

Eligibility for using Cort-Dome, a topical hydrocortisone product, is determined by official regulatory classifications regarding patient health status and age. The rules prioritize mitigating the risk of systemic absorption of the corticosteroid.

Classification Eligibility Statement (Regulatory Basis)
Absolute Contraindication Patients with a history of hypersensitivity (allergy) to hydrocortisone or any component of the specific preparation are prohibited from use. Use is also contraindicated on skin areas with untreated active infections (viral, bacterial, or fungal) as defined in official product labeling.
Restricted/Conditional Use Pediatric Patients: Children are more susceptible to systemic toxicity due to a larger skin-surface-to-body-mass ratio. Use must be strictly limited. Over-the-counter products are not recommended for children under 2 years without consulting a physician.

Pregnancy and Lactation: Use during pregnancy should occur only if the potential benefit justifies the potential risk to the fetus. Caution is advised for nursing mothers. | | Application Restrictions | The treated skin area must not be covered or wrapped with an occlusive dressing (including tight-fitting diapers on infants) unless specifically directed by a medical professional, as this significantly increases systemic absorption. | | Comorbidity Caution | The medicine should be used with caution in patients with conditions like Cushing's syndrome or diabetes, as systemic absorption may worsen these conditions.

These official rules strictly define the populations allowed, prohibited, or restricted from using the medicine, ensuring that its low-potency profile is maintained by controlling absorption risks in vulnerable groups.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official government regulatory documentation for Cort-Dome (topical hydrocortisone) often indicates a limited profile of known interactions, consistent with its low systemic absorption when used as directed.

Documented Interaction Profile

Interaction Type Regulatory Status (Documented)
Drug-Drug Interactions No specific interactions with co-administered medicinal products are known or officially documented as requiring restriction.
Contraindicated Combinations No formal combinations with other medicines are listed as contraindicated due to interaction risk.
Metabolic/PK Interactions No specific CYP enzyme or transporter-mediated interactions are documented for this topical formulation.

Procedural and Non-Medicinal Product Interactions

Regulatory agencies identify specific conditions and non-medicinal products that interact with the medicine's use or absorption profile:

  • Exposure Augmentation: Applying the medication under occlusive dressings or tight-fitting garments (e.g., plastic pants or diapers) augments the systemic absorption of the medicine.
  • Material Incompatibility: The medicine can cause damage and reduce the effect of latex-containing products, such as condoms and diaphragms, upon contact.

Population-Specific Considerations

  • Pediatric Patients: This population may be at an increased risk of systemic effects because their skin surface area is larger relative to their body weight, which can lead to greater systemic exposure.

Mechanism of Action

Cort-Dome (hydrocortisone) is a synthetic glucocorticoid structurally related to endogenous cortisol. It functions as an agonist for the ubiquitous intracellular Glucocorticoid Receptor (GR). Upon passive diffusion into the cell, the molecule binds to the cytoplasmic GR, inducing a conformational change that promotes receptor dissociation from chaperone proteins. The activated ligand-receptor complex then translocates to the cell nucleus.

Within the nucleus, the complex modulates gene transcription primarily through two mechanisms. The first involves direct binding to specific DNA sequences known as Glucocorticoid Response Elements (GREs), resulting in the upregulation of anti-inflammatory genes (e.g., annexin-1/lipocortin-1). The second, often referred to as transrepression, involves physical interaction with and subsequent inhibition of pro-inflammatory transcription factors, such as NF-kappaB and AP-1. This interaction suppresses the transcription of key pro-inflammatory mediators, including cytokines (e.g., IL-1, IL-6, TNF-alpha), chemokines, and enzymes like COX-2 and iNOS.

Downstream consequences include decreased synthesis of arachidonic acid metabolites (prostaglandins and leukotrienes) and suppressed proliferation and activity of T-lymphocytes and macrophages. System-level consequences involve widespread modulation of immune and inflammatory responses, alongside metabolic effects such as increased hepatic gluconeogenesis and altered protein catabolism.

Dosage and Administration Information

Cort-Dome (hydrocortisone) is administered via two primary routes: topical applications, encompassing creams, ointments, lotions, or solutions, and rectal applications, such as suppositories or foams.

The dosage schedule for topical products dictates applying a thin film of the 0.1% to 2.5% strength formulation. This is typically applied in divided doses, ranging from two to four times daily. Rectal administration involves either a single suppository (e.g., 25 mg) or one applicatorful of foam, usually on a twice-daily schedule (morning and night). When using lotions or solutions, standard instructions specify that the container must be shaken well prior to administration.

Administration is subject to time constraints, as treatment is designated as short-term. Topical use is often limited to a course of seven to ten days, while rectal regimens may extend up to approximately eight weeks for specific conditions. A key instruction states that occlusive dressings should not be used over topical applications. For pediatric populations, established clinical guidelines require using the least effective amount for the shortest duration possible, with use in children under two years being restricted.

Recent Clinical Evidence

Cort-Dome: Recent Clinical Evidence

Cort-Dome, a product containing the low-to-intermediate-potency corticosteroid hydrocortisone acetate, is widely utilized for its anti-inflammatory and anti-pruritic (anti-itch) properties. Its clinical efficacy is well-established in the management of various corticosteroid-responsive dermatoses, including eczema (atopic dermatitis) and different forms of dermatitis.

Recent clinical trials and meta-analyses generally reinforce the role of topical hydrocortisone as a foundational and effective treatment for mild to moderate inflammatory skin conditions. For instance, in treating pruritus (itching) associated with dermatitis, studies have demonstrated a significant reduction in severity with a low-dose hydrocortisone acetate formulation, sometimes in combination with other agents, showing a rapid onset of action within one day of application.

Efficacy and Safety Profile

Hydrocortisone is frequently used as a benchmark against which newer topical anti-inflammatory agents are compared, validating its sustained relevance. Its effectiveness is attributed to its mechanism of action, which involves reducing inflammation by inhibiting the release of destructive cellular enzymes and decreasing capillary permeability.

Safety data emphasizes that potential side effects are typically local and mild, such as skin irritation, burning, or dryness. However, the risk of systemic effects, such as the suppression of the hypothalamic-pituitary-adrenal (HPA) axis, and local adverse reactions like skin atrophy (thinning) is higher with prolonged, frequent use, or application over large surface areas, particularly in children. Current evidence supports that these risks can be minimized by following a healthcare provider's instructions for appropriate dose, duration (often measured in weeks), and area of application.

How should Cort-Dome be stored and disposed of?

The storage and disposal of Cort-Dome (hydrocortisone) must adhere strictly to the conditions specified in the official regulatory labeling to maintain product stability and safety.

Storage Conditions

Requirement Specific Condition
Temperature Store at Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F).
Environment Protect from freezing and excessive heat and moisture.
Container Keep in the container it came in and keep the container tightly closed.

Disposal and Safety

  • Child Protection: The product must be stored out of the sight and reach of children at all times.
  • Disposal Method: The best method for discarding unneeded or expired medicine is by using a designated medicine take-back program.
  • Environmental Safety: Unless otherwise instructed, do not dispose of the medication by flushing it down the toilet or pouring it down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagColombia

flagEcuador

flagUSA

Equivalent of Cort-Dome found in:

A-Z Index: